Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Atrion Corporation

Atrion Corporation (ATRI) Stock Overview

Explore Atrion Corporation’s financial performance, market position, analyst ratings, and future outlook.

ATRI●NASDAQ
HealthcareMedical - Instruments & Supplies
$459.92
$0.26(0.06%)
U.S. Market opens in 14h 27m

Atrion Corporation (ATRI)

Meyka AI Score

Z

Key Financials

Market Cap809.4M
P/E Ratio41.74
EPS (TTM)$7.13
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$300.18

ATRI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Atrion Corporation (NASDAQ: ATRI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Atrion Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ATRI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $300.18 for the NASDAQ listing.

Key metrics behind Atrion Corporation's NASDAQ-traded stock include a P/E ratio of 41.74 and a market capitalization of 809.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ATRI on the NASDAQ.

Price Performance (NASDAQ: ATRI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.06%
3-Month Change
2.20%
6-Month Change
7.31%
Year-to-Date (YTD) Change
16.96%
1-Year Change
2.23%
3-Year Change
-35.18%
5-Year Change
-42.00%
All-Time (Max) Change
14317.55%

Contact Information

https://www.atrioncorp.com
972 390 9800
One Allentown Parkway, Allen, TX, 75002-4211

Company Facts

7,120 Employees
IPO DateMar 18, 1980
CountryUS

Frequently Asked Questions